2019
DOI: 10.4322/acr.2019.117
|View full text |Cite
|
Sign up to set email alerts
|

Intraoral EBV-positive sporadic Burkitt lymphoma in an elderly patient with bilateral presentation

Abstract: Sporadic Burkitt lymphoma (SBL) is a variant of Burkitt lymphoma that occurs worldwide, affecting mainly children and young adults. Association with Epstein-Barr virus (EBV) can be identified in approximately 20-30% of cases. Herein we described a case of a 63-year-old male presenting intraoral bilateral mandibular swelling, subjacent to fixed dental prosthesis, with one month of duration. Incisional biopsies were performed, and after two days, the patient was hospitalized due to malaise and breathing difficul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0
2

Year Published

2020
2020
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 22 publications
0
1
0
2
Order By: Relevance
“…Unfortunately, we could not find reports on BL series from the Andean and Caribbean regions of LA, which, most probably, does not represent a low frequency of this lymphoma there. Although there are studies including BL from Mexico, they do not address EBV infection, and there is only one case report from a 63 yo male with an EBV positive intraoral BL [128].…”
Section: Burkitt Lymphomamentioning
confidence: 99%
“…Unfortunately, we could not find reports on BL series from the Andean and Caribbean regions of LA, which, most probably, does not represent a low frequency of this lymphoma there. Although there are studies including BL from Mexico, they do not address EBV infection, and there is only one case report from a 63 yo male with an EBV positive intraoral BL [128].…”
Section: Burkitt Lymphomamentioning
confidence: 99%
“…A diferencia de otros casos, nuestra paciente no mostró sintomatología oftalmológica, lo cual se ha reportado hasta en el 33% de los pacientes. [10][11][12] En cuanto al tratamiento, la ciclofosfamida es el pilar de la quimioterapia, pero asociado a otros fármacos para favorecer la remisión. La duración de la remisión es muy variable, llegando a ser en promedio de 18 meses.…”
Section: Discussionunclassified
“…Asimismo, en cerca de un tercio puede haber manifestaciones oftalmológicas, siendo la proptosis lo más frecuente. [10][11][12][13] Dado lo raro de la presentación, el objetivo de este trabajo es informar de un paciente pediátrico con linfoma de Burkitt a nivel de la nasofaringe.…”
Section: Wwwmedigraphicorgmxunclassified